---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-057888"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:35:00.742551+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Vaccinex CFO Scott Royer to retire March 14; Controller Jill Sanchez named Interim CFO

## Summary
- CFO Scott Royer notified retirement effective March 14, 2024, not due to any disagreement with the company.
- Jill Sanchez, age 52, CPA, to serve as Interim CFO, Principal Financial and Accounting Officer from March 14.
- Sanchez has been Vaccinex's Controller since January 2019; no family relationships or reportable transactions.
- Royer will cease serving as Principal Financial and Principal Accounting Officer upon retirement.

## SEC filing metadata
- accession: 0001193125-24-057888
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312524057888/0001193125-24-057888-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312524057888/d823677d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-057888
- JSON: https://secwatch.observer/filing/0001193125-24-057888.json
- Plain text: https://secwatch.observer/filing/0001193125-24-057888.txt

## Key facts
- Executive change
  Scott E. Royer retired as Chief Financial Officer at VACCINEX, INC..
  - Action: retired
  - Role: Chief Financial Officer
  source text: On February 27, 2024, Scott E. Royer notified Vaccinex Inc. (the “Company”) of his decision to retire from his position as the Company’s Chief Financial Officer effective March 14, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312524057888/0001193125-24-057888-index.htm
- Executive change
  Jill Sanchez was appointed as Interim Chief Financial Officer at VACCINEX, INC..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: effective upon Mr. Royer’s retirement on March 14, 2024, Jill Sanchez, age 52, will serve as the Company’s Interim Chief Financial Officer and as its Principal Financial Officer and Principal Accounting Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312524057888/0001193125-24-057888-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.